Literature DB >> 11501958

The A-Med right heart support for off-pump coronary artery bypass grafting.

U Livi1, S Gelsomino, P Da Col, F Poldini, G Masullo, G Cheli, R Nucifora, R Muzzi, U Da Broi.   

Abstract

BACKGROUND: Off-pump coronary artery bypass grafting (OPCAB) presents several advantages but, mainly due to the impaired diastolic filling of the right ventricle, the displacement of the heart can cause hemodynamic instability. The aim of this study was to investigate the possible role of the A-Med right heart support during OPCAB.
METHODS: We report our early experience with the A-Med system (A-Med, West Sacramento, CA, USA) during OPCAB. The system consists of a coaxial cannula, a microcentrifugal pump and a control console. The coaxial cannula is passed through the right atrium with the tip of the cannula positioned in the main pulmonary artery. Thus the blood is actively removed from the right atrium and returned to the pulmonary artery.
RESULTS: We successfully used this right heart support in 2 patients undergoing elective OPCAB. In both cases the system was used during the exposure of the proximal portion of the obtuse marginal branch. A mean pump flow of 3.2 l/min guaranteed normal cardiac output and hemodynamic stability during the exposure of the posterior target area. No complication occurred and the patients were discharged shortly after surgery.
CONCLUSIONS: In our early experience the A-Med right heart support was safe and effective and allowed achievement of hemodynamic stability during exposure of the posterior areas of the left ventricle.

Entities:  

Mesh:

Year:  2001        PMID: 11501958

Source DB:  PubMed          Journal:  Ital Heart J        ISSN: 1129-471X


  1 in total

1.  Percutaneous Double Lumen Cannula for Right Ventricle Assist Device System: A Computational Fluid Dynamics Study.

Authors:  Francesca Condemi; Dongfang Wang; Gionata Fragomeni; Fuqian Yang; Guangfeng Zhao; Cameron Jones; Cherry Ballard-Croft; Joseph B Zwischenberger
Journal:  Biocybern Biomed Eng       Date:  2016-04-18       Impact factor: 4.314

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.